{"disease":{"id":"acute-myeloid-leukemia-aml-in-adult-patients-60-years-or-older-with-at-least-30-bone-marrow-blasts-and-intermediate-2-or-high-risk-cytogenetic-abnormalities-by-the-european-leukemianet-eln-classification.md","name":"acute myeloid leukemia aml in adult patients 60 years or older with at least 30 bone marrow blasts and intermediate 2 or high risk cytogenetic abnormalities by the european leukemianet eln classification.md"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[],"total":0},"guidelines":[],"source":"Drug Landscape verified database"}